Juva Life, Inc. (TSE:JUVA) has released an update.
Juva Life Inc., a life science company involved in pharmaceutical research and consumer cannabis operations, has announced a delay in filing its annual financial statements for 2023 due to additional audit time required after a recent reorganization. The company has received a management cease trade order and anticipates completing the necessary filings by June 28, 2024, with bi-weekly updates promised in the interim.
For further insights into TSE:JUVA stock, check out TipRanks’ Stock Analysis page.
